Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07329998

The Aim of the Study is to Check Whether Follicular Fluid Evaluation Using a Spectrophotometer Can Differentiate High Quality Oocytes From Low Quality Oocytes. Oocyte Quality Will be Defined Using GDF9, BMP15 and Oocyte Morphology.

Oocyte Quality Assessment Using Spectrophotometer

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

The aim of the study is to check whether follicular fluid evaluation using a spectrophotometer can differentiate high quality oocytes from low quality oocytes. Oocyte quality will be defined using GDF9, BMP15 and oocyte morphology. The correlation between cortisol levels in women and oocyte quality parameters will be estimated.

Conditions

Interventions

TypeNameDescription
PROCEDUREOocyte quality assessment using spectrophotometerOn the OPU (ovum pick-up) day the following blood biochemical markers will be measured as well- Blood interleukins 1-6, cytokine, hormone profile, lipid profile, cortisol. After collecting the oocytes- the Follicular fluid will be sent for the following tests- 1. mid-infrared spectrometry, 2. P, E2, testosterone, cortisol, cytokines, IL 1-6, lipids, fatty acids. 3. BMP-15, GDF-9 and HSPG2 4. GCMS-Gas Chromatography Mass Spectrophotometer

Timeline

Start date
2024-09-22
Primary completion
2025-12-16
Completion
2026-11-01
First posted
2026-01-09
Last updated
2026-01-09

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT07329998. Inclusion in this directory is not an endorsement.